Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......
Drug firm Glenmark Pharmaceuticals on Saturday said it has launched antiviral drug Favipiravir, under the brand name FabiFlu, for the treatment of patients with mild to moderate COVID-19 at a price......
Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of......
Like pharmaceutical companies globally - which used to enjoy a preferential exchange rate in Venezuela - Indian producers have been left badly stung by the collapse of the bolivar currency Indian......
Indian drugmakers expect a slowdown in new generic drug approvals by the US Food and Drug Administration (FDA) to weigh on sales in their largest market for at least two more quarters, due to an......
Glenmark may soon foray into the injectible oncology segment in the US and Europe. The company has already started filing applications for drug approval in these markets. This will mark the......
Glenmark Pharmaceuticals is close to become the first Indian company to develop an original novel chemical entity (NCE) to treat diseases. An NCE is a molecule developed in the early drug discovery......